The illusion of cell immortality by Hayflick, L
Most cancer cell populations can be distinguished from normal
cells by a progressive acquisition of properties that includes
immortality. This was first demonstrated in the early part of the
twentieth century by the finding that rodent tumours could be
serially transplanted indefinitely (Foulds, 1969). By mid century
the immortality of cancer cells was demonstrated in vitro (Earle,
1943), followed by the finding that, contrary to prevailing belief,
cultured normal cells are mortal (Hayflick and Moorhead, 1961;
Hayflick, 1965). We suggested that the finite capacity of normal
cells to replicate was a reflection of ageing or longevity determina-
tion at the cell level, an idea that received substantial support in
subsequent years (Hayflick, 1997, 1998a).
Nevertheless, this distinction between normal and cancer cells
has become blurred because the terms ‘mortality’ and ‘immor-
tality’ are subject to enormous variations in understanding.
In the legal sense the mortality of a human is established in
many countries when a physician certifies that brain death has
occurred. However, acceptable evidence of death varies among
different legal systems. Immortality, on the other hand, was rarely
considered as a legal concept until it became possible in 1980 to
patent self-reproducing life forms (Hayflick, 1998b).
Where certification of human brain death is a prerequisite for
the legal removal of donor tissue, the expectation is that the
remaining organs, tissues or cells that may be taken for transplan-
tation are viable. Thus, legally, the mortality of one organ – the
brain – is assumed to have no immediate effect on the mortality
and subsequent usefulness of the remaining organs.
The determination of mortality and immortality is even more
complex in a stricter biological sense. A common example
given for biological immortality is the alleged indefinite
replicative capacity of unicellular organisms because cadavers
do not result from fission replication and an endless lineage of
viable cells are produced. However, this example fails to distin-
guish between individual and population mortality and immor-
tality. Individual micro-organisms, like individual humans are
mortal, but as populations both appear to be immortal. The
‘cadavers’ of organisms that divide by fission are their
molecules and atoms that become increasingly diluted and
ultimately lost in those cells at the leading edge of the
expanding population. Or, these molecules are lost to further
progeny when fission products die.
Most micro-organisms, like higher life forms, are now known to
possess mechanisms for genetic recombination (Maynard Smith et
al, 1993). In populations of unicellular forms, a narrow lineage
may appear to reproduce endlessly but for the same reason that a
fraction of the population of higher organisms, like humans,
appears to reproduce endlessly. Thus, the finality of life in
individual unicellular forms may be no different from mortality in
multicellular forms. But, populations of each are immortal, or
potentially so, and for the same reasons.
DEFINITIONS
The most stringent definition of immortality is a life form capable
of indefinite survival in conditions where no changes have
occurred in molecular composition from some arbitrary beginning.
However, this condition is incompatible with life, if for no other
reasons than it precludes metabolism and replication.
The only condition that comes close to meeting this definition is
cryogenic preservation where cells appear to be capable of indefi-
nite survival at temperatures that approach absolute zero. Under
these conditions life processes are arrested but life is not being
lived in the sense that metabolic activity is radically reduced or
does not occur at all.
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has been cryogenically preserved in a viable state for over 38
years. This is the longest period of time that a viable normal
human cell population has ever been preserved. Absent failure to
top up the liquid nitrogen freezer periodically, these cells can be
considered to be immortal. But, these cells are not immortal in the
sense that metabolism has continued uninterrupted during the past
38 years.
A more liberal definition of biological immortality would be 
the indefinite survival of a life form whose vital life processes
function indefinitely. Yet, this definition is not without difficulty
because the quality of molecular ‘sameness’ is lost. This concept
of molecular identity is best illustrated by challenging a tenet of
modern biology.
In 1891 August Weismann proposed that the germ plasm is
immortal. Yet, the repeated replication and repair of DNA results
in molecules that do not contain atoms of the same nucleotides
present in the DNA of a founding cell. Also, different genes are
contributed from each parent at every fusion that further
contributes to loss of sameness. Finally, given equal distribution at
each division, other molecules or atoms present in a founding cell
are not likely to be present after the clone has produced a lineage
of about fifty population doublings.
The reasoning is that 3.3 ´ 109 molecules of H2 are roughly
equivalent to the mass of a human fibroblast so that the first cell in
the lineage must consist entirely of H2 to permit one molecule to
reach each cell at the 50th doubling (Hayflick and Moorhead,
1961). This assumes equal distribution of molecules at each
division. Because cells are not composed entirely of the smallest
molecule and because molecular turnover and repair occur, the
likelihood is that those cells present well before the lineage
reaches 50 population doublings retain few, if any, of the mole-
cules present in the founding cell.
Thus, there is a tenable argument that the germ plasm is not
immortal because molecules at the end of a lineage of zygotes are
not identical to those in the founding gametes. A closer approxi-
mation to fidelity is that each zygote in the lineage contains the
same genetic information as does its precursors following fertiliza-
tion. This is dubious because of the occurrence of mutations, one
of the few universal properties of life.
Cells at the leading edge of any long lineage do not have the
identical molecular content as existed in the founding cell. Even
in non-dividing cells, molecular turnover must occur (Lindahl,
1993) leading to the conclusion that, like dividing cells, non-
dividing cells also are not molecularly identical after the passage
of time.
Thus, August Weismann may have been wrong not only
because molecular turnover is inevitable in all cell lineages but
because the alleged immortality of the germ plasm takes place
only under conditions of periodic genetic recombination. By
themselves gametes and the germ plasm are not an immortal
lineage.
MORTALITY AND AGEING
Another example of the difficulty of defining mortality impinges
on our concept of age. For example, there is a common belief that
Redwood trees and Bristle cone pines can achieve great age.
Yet, the cells in these trees, alleged to be thousands of years old,
are dead. The living cells in the needles, cambium layer and root
hairs are no older than about 30 years (Hayflick, 1996). Humans,
older than 30 years, who stand in awe of Redwood trees should
more accurately stand in awe of their own living post mitotic
neurons that are older than the tree’s living cells.
The quaking aspen clones estimated to be over 10 000 years old
(Cooke, 1985), creosote bushes (Larrea tridentate) said to be 
11 700 years old (Vasek 1980), and the 1400 year-old bracken
ferns (Pteridium aquilinum) (Oinenen, 1967) all suffer from the
same criticism. Finally, the sea anemone, frequently cited as an
example of an organism hundreds of years old (Hughes, 1989), if
not immortal, is a colonial animal whose component cells turnover
regularly thus making an argument for their immortality, or great
longevity, spurious.
Animals that do not reach a fixed size in adulthood (examples
include the American lobster, some reptilians, many sport and
deep sea fish) either do not age, or the process is so slow that the
rate is imperceptible. They are not immortal because, like animals
that do age, there is an annual likelihood of death attributable to
disease, accident or predation (Hayflick, 1996).
These examples represent the difficulty in defining biological
mortality and immortality that can become serious impediments to
understanding and accurate communication.
In its simplest, though still inaccurate form, biological mortality
is usually defined as the death of an organism or the termination of
its lineage. Immortality would be defined as the indefinite survival
of a single organism or of a replicating population regardless of
molecular turnover. Imperfect as these definitions are, they do
have limited use in understanding some of the fundamental differ-
ences between normal and cancer cells.
IMMORTAL CANCER CELLS
One of the striking characteristics of cultured cancer cell lines is
the property of population immortality.
This distinction first became apparent to us about 40 years ago
when we observed that, contrary to the prevailing belief that all
cultured cells were potentially immortal, cultured normal cells
have a limited capacity for replication (Hayflick and Moorhead,
1961). Because we knew that several populations of apparently
immortal cancer cell populations existed – best exemplified by
HeLa – we proposed that normal cells are mortal and that
immortal cell populations had acquired cancer cell properties
(Hayflick and Moorhead, 1961; Hayflick, 1965).
Our results led us to conclude that these two classes of cultured
cells bear the following relationship to their in vivo counterparts
(Hayflick 1965):
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Heteroploid cell lines : Transplantable tumours = Diploid cell strains : Normal somatic tissue
(in vitro) (in vivo) (in vitro) (in vivo)
1. Heteroploid 1. Diploid
2. Cancer cells 2. Normal cells
3. Indefinite growth 3. Finite growthThis was the first effort to classify cell populations based on the
properties of mortality or immortality. Had it not been shown that
normal cells are mortal, the subsequent interest in mechanisms that
lead to immortalization would not have been appreciated. The
acquisition of the property of immortality by normal cells
currently is a fundamental underpinning of both aging and cancer
research. In the following discussion the terms “cell line” and “cell
strain” will be used as defined above.
The acquisition by a cell strain of the properties described above
for a cell line is defined here as ‘transformation’.
IMMORTALITY DISPROVED
In protozoa where an individual is isolated and continuously sepa-
rated from daughter cells as they are produced (‘isolate’ cultures),
mortal lineages always occur, thus settling a controversy of 50
years duration (Bell, 1988). Alleged ‘immortal’ cell lines, like
HeLa, that have been cultivated continuously for decades, but
never studied as isolate cultures, cannot be assumed to be
immortal.
Isolate cultivation of cell lines could reveal that immortaliza-
tion, a major characteristic of transformation, may be only indi-
rectly dependent upon interventions using radiation, chemical
carcinogens, oncogenic viruses like SV40, transfection with
particular oncogenes like c-myc or activation of normal cellular
proto-oncogenes.
These procedures may confer upon mortal cells the ability to
periodically undergo sexual recombination that may be the ulti-
mate prerequisite for population immortality in cell lines. Like
unicellular populations of protozoa or micro-organisms, cell lines
may achieve population immortality only after an accumulated
load of deleterious mutations (Muller’s Ratchet) has been disposed
of by sexual recombination (mixis). To ‘immortalize’ a normal cell
population may mean to induce some cells in the population to
acquire the ability to undergo mixis. Somatic cell genetic recombi-
nation is predicted from this reasoning and would be a most impor-
tant finding.
The appearance and disappearance of gap junctions or intercel-
lular channels known as connexins which link cells to each other
provide important opportunities to explore the possibility that
genetic information may flow between somatic cells (Paul and
White, 1999).
Like the myth of Alexis Carrel’s immortal chick heart fibro-
blasts (Witkowski 1979, 1980, 1985), the 50-year-old assumption
that cell lines are immortal may also be a myth because the occur-
rence of mixis has not been disproved. A more recent assumption
of immortality has been made for cultured embryonic stem cells,
yet proof that these cells can be propagated continuously for years
with retention of normal properties, even in the absence of genetic
recombination, has yet to been demonstrated.
MECHANISMS OF IMMORTALIZATION
Continuously replicating cell lines may arise spontaneously from
normal cell strains by unknown processes or created in the labora-
tory as described above.
It has been recognized for many years that there is great species
variability in the capacity of cells to spontaneously transform
(Macieira-Coelho, 1999). Least likely are human and chicken cells
and the easiest are rodent cells but even they do not express a
frequency of occurrence greater than one in a million (Kraemer et
al, 1986). There is no good explanation for these differences. A
possibility that has not been excluded might be that cells of species
most likely to transform in vitro are derived from highly inbred
laboratory animals.
Hybridization studies between human mortal and immortal
populations reveal that immortality is a recessive trait (Ran and
Periera-Smith, 2000). The opposite is true for rodent cells where
immortality appears to be a dominant trait. Immortal murine
hybridomas can be obtained from the fusion product of immortal
myeloma cells with mortal antibody-producing lymphocytes
(Kohler and Milstein, 1975), a property of murine cells that also
may be linked to the relative ease with which they spontaneously
transform.
The process of immortalization appears to be one of the earliest
events in the stepwise progression necessary for full expression of
the transformed phenotype. In Syrian and Chinese hamster, mouse,
rat and pig cell immortality is followed by anchorage indepen-
dence, reduced serum growth factor requirements and finally
tumorigenicity (Kraemer et al, 1986). Human cells, however, may
reveal tumorigenic properties before they reveal immortality
(Sack, 1981).
THE IDEA OF A COUNTER
Three of our early observations led us to conclude that normal,
mortal, human cells must contain a replication counting mecha-
nism. First, was the reproducibility of our finding that human
fibroblasts from different embryonic donors underwent a finite
number of population doublings that spanned a narrow range
between 40 and 60. Second, cells frozen at any population
doubling level from 1 to 50 retained memory of that level until
reconstitution so that the total number of population doublings
traversed both before and after freezing totalled 50 (Hayflick and
Moorhead, 1961; Hayflick, 1965). The ability of WI-38 to
remember at what population doubling it is when frozen is as accu-
rate today as it was when I first developed the strain in 1962. After
38 years of cryopreservation, WI-38’s memory has been retained
without loss.
The third evidence for the existence of a counter resulted from
our efforts in 1975 to determine the location of the putative
counter. By employing enucleation techniques in which the nuclei
of old and young cultured cells were fused to opposite aged
enucleated cytoplasts we concluded that the replicometer was
located in the nucleus (Wright and Hayflick, 1975; Muggleton-
Harris and Hayflick, 1976).
The search for the counting mechanism remained virtually
quiescent for the next 15 years. Then, the remarkable convergence
of data from several diverse fields of research with our own
resulted in an explosion of fascinating information that has not
only determined the location of the counting mechanism but has
identified its molecular structure. (For more detailed reviews see
Blackburn and Greider, 1995; Kipling, 1995; Chiu and Harley,
1997; Greider, 1998; Hayflick, 1997.)
THE TELOMERE REPLICOMETER
As suggested cell mortality and immortality are inextricably linked to
ageing and cancer (Hayflick, 1965). Consequently, the importance of
identifying the putative counter would be difficult to exaggerate.
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chronometer because these devices measure the passage of time.
The replicative limit of normal cells is directly related to the
number of cell doublings, or more precisely DNA replications.
Thus, the putative mechanism should be more properly referred to
as an event counter. Because a meter is a device that measures
quantity, or counts events, this would justify the suggestion that
the term ‘replicometer’ be used in lieu of ‘clock’.
In a 1938 lecture given by Hermann Muller (1962) and followed
by the work of Barbara McClintock (1941), the tips of chromo-
somes were reported to contain discrete structures called telomeres.
Although the precise role that these structures played was unclear,
there was some evidence that telomeres prevented chromosomes
from fusing to each other end to end and that they permitted the
attachment of chromosome ends to the nuclear envelope.
In an entirely different area of biological inquiry it was
observed, in the early 1970s, that the properties of DNA poly-
merase prevent it from fully replicating the linear ends of DNA
(Olovnikov, 1971; 1973; 1996; Watson, 1972). This ‘end-replica-
tion problem’ is the inability of DNA polymerase to completely
replicate the 3¢ end of linear duplex DNA.
In the late 1960s, Alexey Olovnikov, who had just heard a
lecture on our work, wondered how normal cells might have a
limited capacity to replicate as he entered a Moscow subway
station (Olovnikov, 1996). When the train stopped at the station he
had a remarkable flash of insight. Olovnikov saw an analogy
between the train, which represented the DNA polymerase, and
the track that represented the DNA. If the train engine were imag-
ined to be the polymerase that replicated the DNA track, the first
segment of DNA would not be replicated because it was under-
neath the engine at the start. This was analogous to the ‘end-repli-
cation problem’. Olovnikov realized that this repeated shortening
of the DNA molecule at each round of DNA replication might
explain our finding that normal cells can only replicate a specific
number of times. James Watson independently arrived at a similar
solution in 1972.
Because the loss of DNA that contained vital genetic informa-
tion at each division seemed unlikely, Olovnikov reasoned that
telomeres might consist of repeated nucleotide sequences that did
not contain genetic information but behaved much like a buffer. At
each round of DNA replication the buffer would simply lose what
portion of the DNA molecule was not copied (the telomeric ends)
and thus protect downstream genes. The length of the buffer would
determine the number of rounds possible for DNA replication.
Olovnikov’s imaginative solution to the end-replication
problem, although published in 1971 in Russian and in 1973 in
English, languished in the literature for several years until labora-
tory reports emerged that have substantially supported his
armchair speculations.
TELOMERE STRUCTURE DISCOVERED
In 1978, Elizabeth Blackburn, working with the ciliated proto-
zoan, Tetrahymena, found that telomeres consisted of a simple
sequence of hexameric repeats of the nucleotides TTGGGG
(Blackburn and Gall, 1978). It was later found that the telomere
repeat sequence in human cells was TTAGGG (Moyzis et al,
1988). From slime moulds to humans, telomeres consist of thou-
sands of repeats of the highly conserved sequence TTAGGG
(Henderson, 1995).
In 1986 Howard Cooke suggested that telomere shortening
might occur in human cells (Cooke and Smith, 1986). Later Calvin
Harley, who had worked for several years with my system of
senescent human cells, had a fortuitous discussion with Carol
Greider and both decided to explore the possibility that the limited
proliferative capacity of cultured normal cells might be explained
by diminishing telomere length. They did, indeed, find that the
mean telomere length decreased by 2 to 3 kilobase pairs during the
entire in vitro lifetime of several strains of cultured normal human
diploid fibroblasts (Harley et al, 1990).
The decrease was found to be progressive and averaged 50 base
pairs per population doubling (Levy et al, 1992). The telomere
shortening seen in ageing cultured normal human fibroblasts also
occurs in many other normal cultured and in vivo cell types.
Allsopp et al (1992) reported that after analysing the cultured
normal fibroblasts from 31 human donors, aged from several
months to 93 years, a striking correlation, valid over the entire age
range, was found between replicative capacity and initial telomere
length. Thus, cell strains with shorter telomeres underwent signifi-
cantly fewer doublings than those with longer telomeres.
Telomeric shortening appears to be the replicometer that deter-
mines the number of times that a normal cell is able to divide.
Once a threshold number of telomeric (TTAGGG)n repeats is
reached, downstream events presumably are triggered that signal
the cessation of DNA replication. Wright and Shay (1992) have
offered an alternative explanation of how telomere shortening acts
as a replicometer. Their telomere positional effect explanation of
cell senescence is based on a novel two-stage model.
ACHIEVING IMMORTALITY
One essential question remains: How do immortal cell lines avoid
telomere shortening that, if it occurs, would lead to their demise?
The answer to this critical question also originated in studies
with Tetrahymena by Greider and Blackburn (1985), who discov-
ered the ribonucleoprotein enzyme terminal transferase called
telomerase. They found that telomeres are synthesized de novo by
telomerase, a ribonucleoprotein enzyme that extends the 3¢ end of
telomeres and thus elongates them. This ribonucleoprotein
complex contains a reverse transcriptase and RNA template for the
synthesis of the repeated sequence (Shippen-Lentz and Blackburn,
1990). It was simultaneously reported that cancer cells have
shorter telomeres than do adjacent normal cells (de Lange et al,
1990; Hastie et al, 1990) thus providing the first link for the role of
telomeres in cancer biology.
Telomerase was later found to occur in extracts of immortal
human cell lines (Morin, 1989; Counter et al, 1992) and in about
90% of all human tumours studied (Chiu and Harley, 1997).
Subsequently, the telomerase RNA component (Feng et al, 1995)
and the catalytic portion of the enzyme were cloned (Nakamura et
al, 1997). Telomerase is the only known reverse transcriptase that
is necessary for normal cell activity.
Unlike normal mortal cultured cell strains, most immortal cell
lines produce telomerase. Thus, the telomeres of most cell lines do
not shorten with serial passage in vitro.
In recent years telomerase expression has been found in several
classes of normal cells. These include fetal tissue, normal bone
marrow stem cells, testes, peripheral blood lymphocytes, skin
epidermis and intestinal crypt cells (Chiu and Harley, 1997). Prior
to the 10th post-natal week in humans the RNA component of
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(Yashima et al, 1998). All of these normal cells have high turnover
rates or are in a continuously replicating pool of differentiating
cells. The level of telomerase activity found in normal cell popula-
tions is, per cell, significantly less than that found in cancer cells
(Chiu and Harley, 1997).
The observation of telomere attrition as normal cells divide,
provides the first direct evidence for the putative replicometer.
This, in combination with the discovery of the enzyme telomerase,
has gone very far in explaining why most normal somatic cells
have a finite capacity to replicate in vivo and in vitro and how
immortal cancer cells circumvent this inevitability.
In 1998 it was reported that normal, mortal, human cell strains
could be immortalized with apparent retention of their normal
properties by transfecting them with vectors encoding the human
telomerase catalytic subunit (Bodnar et al, 1998). Thus, the repli-
cometer can be purposefully circumvented. This has provided
direct evidence proving the role of telomere shortening in cell
senescence and telomerase expression in cell immortality.
This discovery has profound theoretical and practical implica-
tions that include the immortalization of highly differentiated
normal human cell types for the production of medically useful
proteins.
Because exquisitely sensitive methods exist for the detection of
telomerase in a single cell, this procedure is being exploited as a
diagnostic tool to detect the presence of cancer cells in clinical
specimens. Other researchers are exploring the possibility that
telomerase inhibitors might be found that could be used therapeu-
tically in the treatment of cancer (de Lange and Jacks, 1999; Zhang
et al, 1999).
An intriguing possibility that has not yet been explored is the
role that telomerase might play in the induction of genetic recom-
bination which, as indicated earlier, might be a prerequisite for
immortalization.
As indicated earlier, animals that do not reach a fixed size in
adulthood either do not age or the rate is undetectable. Fascinating
recent findings reveal that in the rainbow trout (Oncorhynchus
mykiss), an animal with imperceptible age changes, and unlike
animals that do age, high telomerase activity has been found in the
cells of all of the organs analysed (Klapper et al, 1998).
TELOMERE ATTRITION AS A LONGEVITY
DETERMINATOR
Telomere attrition may be better understood as a measure of
longevity determination than it might be as a cause of age changes.
After reproductive maturity in animals that age, the level of
remaining physiological reserve determines longevity. The reserve
does not renew at the same rate that it incurs losses because mole-
cular disorder increases at a rate greater than does capacity for
repair. This increase in molecular disorder is aging which
increases vulnerability to predation, accidents or disease
(Hayflick, 1998a).
Hundreds of biological changes occur in normal cells as they
replicate in vitro (Hayflick, 1980) resulting in increasing molec-
ular disorder and loss of cell function. Thus, the number of popula-
tion doublings that a cell strain is capable of undergoing and that is
determined by telomere length, may be the in vitro expression of
maximum potential longevity. The hundreds of molecular disor-
ders that herald the approaching loss of replicative capacity, and
diminution of telomere length, are age changes. When molecular
disorder occurs in dividing cells in vivo, post mitotics may also be
affected and both may then reveal increasing vulnerability to
pathology and subsequent death of the individual well before
species maximum longevity is reached (Hayflick, 1996).
ORDINARY MORTALS
It is probable that biological immortality has been a part of human
thinking since the first humans realized their own mortality.
Immortality, as a concept, appeared in writings at least 3500 years
ago, was a major goal in alchemy, and in the last half of this
millennium drove vast explorations in search of the fountain of
youth (Hayflick, 1996). In today’s iteration, the pursuit of great
longevity is driven by the belief that a particular diet, life style or
concoction will achieve the desired result.
The serious problems that could occur if immortality or extreme
longevity was to become possible have been the theme of much of
our literature, starting with Greek mythology in which the Trojan
Tithonus loves Eos, the Goddess of dawn. At her request, Zeus
makes Tithonus immortal but, unfortunately, Eos neglects to also
ask that he not age. Jonathan Swift rediscovered this theme in his
immortal, but continuously aging, Struldbrugs.
The fact that immortality, in its stricter definitions has never
been demonstrated, even in unicellular forms, provides strong
support for the likelihood, if not the hope, that it will not be found
to occur in higher forms.
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